Background: Severe coronavirus disease 2019 (COVID-19) is characterized, in part, by an excessive inflammatory response. Evidence from animal and human studies suggests that vagus nerve stimulation can lead to reduced levels of various biomarkers of inflammation. We conducted a prospective randomized controlled study (SAVIOR-I) to assess the feasibility, efficacy, and safety of non-invasive vagus nerve stimulation (nVNS) for the treatment of respiratory symptoms and inflammatory markers among patients who were hospitalized for COVID-19 (ClinicalTrials.gov identifier: NCT04368156).
Become a Part of the Vagus Nerve Society
THE VAGUS NERVE SOCIETY IS OPEN TO SCIENTISTS AND CLINICIANS FROM ALL DISCIPLINES.
To become a charter member please fill out the form below. Membership is currently free!